BioCardia BCDA
NASDAQ BCDA
$1.02 +0.01 (+0.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

BioCardia (BCDA) Selling, General & Administrative (2010 - 2026)

Updated

BioCardia (BCDA) recorded Selling, General & Administrative of $730,000 in Q2 2026, up 6.9% from $683,000 a year earlier but down 29.2% from the prior quarter.

Analysis

BioCardia (BCDA) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a TTM basis, BioCardia's Selling, General & Administrative came in at $3.2 million as of Jun 30, 2026, down 11.4% year-over-year; for FY2025, it was $3.32 million, down 9.7% from FY2024.

  • Annual Selling, General & Administrative has declined for six straight years, with a five-year compound annual growth rate of -10.8% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $3.67 million in FY2024 (-16.5%), $4.4 million in FY2023 (-0.5%), $4.42 million in FY2022 (-13.1%) and $5.09 million in FY2021 (-13.2%).
  • Quarterly Selling, General & Administrative has ranged from $552,000 in Q3 2025 to $1.43 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative rose in two of the last eight quarters, with an average decline of 10.0%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 16.9% in Q4 2021, against a decline of 35.2% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.03 million (Q1 2026), $885,000 (Q4 2025) and $552,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 BioCardia 12.21 Mn -649,799.44 - 730,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 730,000.00
Mar 31, 2026 1.03 Mn
Dec 31, 2025 885,000.00
Sep 30, 2025 552,000.00
Jun 30, 2025 683,000.00
Mar 31, 2025 1.20 Mn
Dec 31, 2024 906,000.00
Sep 30, 2024 825,000.00
Jun 30, 2024 852,000.00
Mar 31, 2024 1.09 Mn
Dec 31, 2023 941,000.00
Sep 30, 2023 1.08 Mn
Jun 30, 2023 1.18 Mn
Mar 31, 2023 1.19 Mn
Dec 31, 2022 924,000.00
Sep 30, 2022 1.13 Mn
Jun 30, 2022 1.17 Mn
Mar 31, 2022 1.20 Mn
Dec 31, 2021 1.43 Mn
Sep 30, 2021 1.29 Mn
API Access

BioCardia Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BCDA&period=max&api_key=YOUR_API_KEY